跳至主要内容
临床试验/NCT05026710
NCT05026710已完成不适用

Better Lithotripsy and Ureteroscopy Evaluation of Stenting (BLUES) A Pragmatic Randomized Multi-center Comparative Effectiveness Study

University of Michigan10 个研究点 分布在 1 个国家目标入组 224 人开始时间: 2021年12月2日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
224
试验地点
10
主要终点
Change in Patient-Reported Outcomes Measurement Information System (PROMIS®) Scores of Pain-intensity at 7 to 10 Days

研究概览

简要总结

This multi-center trial is being completed to compare patient outcomes related to the Imajin silicone stent in comparison to non-silicone polyurethane stents after ureteroscopy.

Eligible participants will be enrolled and randomly assigned to receive the Imajin silicone stent or a non-silicone stent. In addition, the participants will complete questionnaires and have follow-up information collected (approximately 60 days after surgery).

The trial hypothesizes that a ureteral stent made of silicone, will have superior outcomes when compared to non-silicone stents.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Stated willingness to comply with all study procedures and availability for the duration of the study
  • •Diagnosed with unilateral renal and/or ureteral stones with the largest less than or equal to (≤)2.0 cm in size measured on abdominal x-ray, Ultrasound or computerized tomography (CT) scan
  • •Renal stone defined as only renal location of stone(s).
  • •Ureteral stone defined as ureteral only or ureteral and renal stone(s).
  • •Planned unilateral ureteroscopy with stent placement without stent string.
  • •Ability to take oral medication.
  • •Ability and willingness to complete and adhere to survey questions and responses throughout study duration.

排除标准

  • •Known planned secondary or staged procedure
  • •Presence of anatomical anomalies (for example (e.g.) solitary, horseshoe, fused crossed ectopia, pelvic kidney)
  • •Presence of any prior urinary diversion (e.g. ileal conduit, orthotopic neobladder)
  • •Presence of any indwelling ureteral stent prior to ureteroscopy
  • •Presence of any indwelling nephrostomy tube prior to ureteroscopy
  • •Ancillary ureteroscopy to treat residual fragments after percutaneous renal stone surgery
  • •Renal stone located in calyceal diverticulum
  • •No indication for stent placement (e.g. spontaneous passage)
  • •Bladder stone location.
  • •Pregnancy or lactation
  • •Known allergic reactions to polyurethane or silicone

研究组 & 干预措施

Non-silicone (Polyurethane/Percuflex) ureteral stent (any manufacturer).

Experimental

干预措施: Non-silicone (Polyurethane/Percuflex) ureteral stent (any manufacturer) (Device)

Silicone (Coloplast Imajin Hydro) ureteral stent

Experimental

干预措施: Silicone (Coloplast Imajin Hydro) ureteral stent (Device)

结局指标

主要结局

Change in Patient-Reported Outcomes Measurement Information System (PROMIS®) Scores of Pain-intensity at 7 to 10 Days

时间窗: Baseline, 7 to 10 days: Participants can fill out the survey at any time between 7 to 10 days after surgery.

This is a 3-item survey which participants select a response for each item from 1=no pain to 5=very severe for intensity of their pain. The sum of responses is then converted into a T-score that ranges from 36.3 to 81.8, with higher scores indicating worse pain intensity. Change is defined as the difference in T-score from baseline to 7-10 days after surgery.

Change in Patient-Reported Outcomes Measurement Information System (PROMIS®) Scores of Pain-interference at 7 to 10 Days

时间窗: Baseline, 7 to 10 days: Participants can fill out the survey at any time between 7 to 10 days after surgery.

This is a 6-item survey which participants select a response for each item from 1=not at all to 5=very much for how much pain interfered with their life. The sum of responses is then converted into a T-score that ranges from 41.0 to 78.3, with higher scores indicating worse pain interference. Change is defined as the difference in T-score from baseline to 7-10 days after surgery.

次要结局

  • Change in National Institutes of Health (NIH) Lower Urinary Tract Dysfunction Research Network (LURN) Symptoms Index (SI)-10 Scores at 7 to 10 Days(Baseline, 7 to 10 days: Participants can fill out the survey at any time between 7 to 10 days after surgery.)
  • Change in Patient-Reported Outcomes Measurement Information System (PROMIS®) Scores of Pain-intensity at 4 to 6 Weeks(Baseline, 4 to 6 weeks: Participants can fill out the survey at any time between 4 to 6 weeks after surgery.)
  • Change in Patient-Reported Outcomes Measurement Information System (PROMIS®) Scores of Pain-interference at 4 to 6 Weeks(Baseline, 4 to 6 weeks: Participants can fill out the survey at any time between 4 to 6 weeks after surgery.)
  • Change in NIH LURN SI-10 Scores at 4 to 6 Weeks(: Baseline, 4 to 6 weeks: Participants can fill out the survey at any time between 4 to 6 weeks after surgery. Baseline, 4 to 6 weeks: Participants can fill out the survey at any time between 4 to 6 weeks after surgery.)
  • Composite Healthcare Utilization Metric Within 30 Days (WinRatio)(up to 30 days)
  • Abnormal Imaging Findings Within 60 Days(up to 60 days)
  • Stone-free Rates Within 60 Days(up to 60 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Khurshid Ghani

Associate Professor of Urology

University of Michigan

研究点 (10)

Loading locations...

相似试验